{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:39:56Z","timestamp":1761597596667,"version":"3.41.0"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2015,4,13]],"date-time":"2015-04-13T00:00:00Z","timestamp":1428883200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0123113","type":"journal-article","created":{"date-parts":[[2015,4,15]],"date-time":"2015-04-15T18:58:16Z","timestamp":1429124296000},"page":"e0123113","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Immunomodulator-Based Enhancement of Anti Smallpox Immune Responses"],"prefix":"10.1371","volume":"10","author":[{"given":"Osmarie","family":"Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maite","family":"Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saritza","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom\u00e1s","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond L.","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eddy","family":"R\u00edos-Olivares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Otero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,4,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1128\/MMBR.55.1.80-122.1991","article-title":"Poxvirus pathogenesis","volume":"55","author":"RM Buller","year":"1991","journal-title":"Microbiol Rev"},{"issue":"Suppl 4","key":"ref2","doi-asserted-by":"crossref","first-page":"D7","DOI":"10.1016\/j.vaccine.2011.06.080","article-title":"The eradication of smallpox\u2014an overview of the past, present, and future","volume":"29","author":"DA Henderson","year":"2011","journal-title":"Vaccine"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3201\/eid1704.101865","article-title":"Should remaining stockpiles of smallpox virus (variola) be destroyed?","volume":"17","author":"RS Weinstein","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"ref4","first-page":"4","article-title":"Smallpox is a dormant volcano","volume":"53","author":"D K L'Vov","year":"2008","journal-title":"Vopr Virusol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1177\/0897190012456366","article-title":"Bioterrorism: pathogens as weapons","volume":"25","author":"PD Anderson","year":"2012","journal-title":"J Pharm Pract"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/477150a","article-title":"Biodefence since 9\/11: The price of protection","volume":"477","author":"EC Hayden","year":"2011","journal-title":"Nature"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3121\/cmr.1.2.85","article-title":"Bioterrorism preparedness: the smallpox vaccine debate","volume":"1","author":"SS Qutaishat","year":"2003","journal-title":"Clin Med Res"},{"key":"ref8","first-page":"84","article-title":"Expected adverse events in a mass smallpox vaccination campaign","volume":"5","author":"AR Kemper","year":"2002","journal-title":"Eff Clin Pract"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1016\/j.vaccine.2004.10.052","article-title":"Reactions to small pox vaccine in naive and previously-vaccinated individuals","volume":"23","author":"C Auckland","year":"2005","journal-title":"Vaccine"},{"key":"ref10","first-page":"1","article-title":"Smallpox vaccination and adverse reactions. Guidance for clinicians","volume":"52","author":"J Cono","year":"2003","journal-title":"MMWR Recomm Rep"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1016\/j.vaccine.2005.03.029","article-title":"Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challenge","volume":"24","author":"C Empig","year":"2006","journal-title":"Vaccine"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0264-410X(96)00260-5","article-title":"Development of a multicomponent candidate vaccine for HIV-1","volume":"15","author":"JJ Kim","year":"1997","journal-title":"Vaccine"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1086\/427265","article-title":"Smallpox vaccine does not protect macaques with AIDS from a lethal monkeypox virus challenge","volume":"191","author":"Y Edghill-Smith","year":"2005","journal-title":"J Infect Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1086\/374716","article-title":"Smallpox vaccination and the patient with an organ transplant","volume":"36","author":"LK Dropulic","year":"2003","journal-title":"Clin Infect Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1034\/j.1600-6143.2003.00145.x","article-title":"Smallpox and live-virus vaccination in transplant recipients","volume":"3","author":"JA Fishman","year":"2003","journal-title":"Am J Transplant"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.ajog.2004.07.014","article-title":"Pregnancy discovered after smallpox vaccination: Is vaccinia immune globulin appropriate?","volume":"191","author":"PG Napolitano","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1146\/annurev.immunol.15.1.617","article-title":"DNA vaccines","volume":"15","author":"JJ Donnelly","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1096\/fasebj.12.15.1611","article-title":"Modulating the immune response to genetic immunization","volume":"12","author":"AD Cohen","year":"1998","journal-title":"FASEB J"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1515\/BC.2001.068","article-title":"Revealing the potential of DNA-based vaccination: lessons learned from the hepatitis B virus surface antigen","volume":"382","author":"R Schirmbeck","year":"2001","journal-title":"Biol Chem"},{"key":"ref20","first-page":"254","article-title":"DNA Vaccines for Prostate Cancer","volume":"8","author":"DG McNeel","year":"2012","journal-title":"Curr Cancer Ther Rev"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1128\/CVI.00162-06","article-title":"A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial","volume":"13","author":"JE Martin","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0065-2660(05)55002-8","article-title":"Human clinical trials of plasmid DNA vaccines","volume":"55","author":"MA Liu","year":"2005","journal-title":"Adv Genet"},{"issue":"Suppl 2","key":"ref23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1423-0410.2000.tb00037.x","article-title":"DNA vaccines","volume":"78","author":"J Reimann","year":"2000","journal-title":"Vox Sang"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/S0140-6736(97)09440-3","article-title":"Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients","volume":"351","author":"S Calarota","year":"1998","journal-title":"Lancet"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.4049\/jimmunol.163.4.2330","article-title":"Immune responses in asymptomatic HIV-1-infected patients after HIV-DNA immunization followed by highly active antiretroviral treatment","volume":"163","author":"SA Calarota","year":"1999","journal-title":"J Immunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1086\/515613","article-title":"First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response","volume":"178","author":"RR MacGregor","year":"1998","journal-title":"J Infect Dis"},{"key":"ref27","first-page":"149","article-title":"Membrane cell fusion activity of the vaccinia virus A17-A27 protein complex","volume":"10","author":"G Kochan","year":"2008","journal-title":"Cell Microbiol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1128\/JVI.56.2.482-488.1985","article-title":"Isolation and characterization of neutralizing monoclonal antibodies to vaccinia virus","volume":"56","author":"JF Rodriguez","year":"1985","journal-title":"J Virol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1128\/JVI.66.1.386-398.1992","article-title":"Identification and characterization of vaccinia virus genes encoding proteins that are highly antigenic in animals and are immunodominant in vaccinated humans","volume":"66","author":"WE Demkowicz","year":"1992","journal-title":"J Virol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1067\/mjd.2000.107808","article-title":"Immunomodulatory and pharmacologic properties of imiquimod","volume":"43","author":"DN Sauder","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0192-0561(98)00068-X","article-title":"Imiquimod applied topically: a novel immune response modifier and new class of drug","volume":"21","author":"RL Miller","year":"1999","journal-title":"Int J Immunopharmacol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/ni758","article-title":"Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway","volume":"3","author":"H Hemmi","year":"2002","journal-title":"Nat Immunol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJMoa072685","article-title":"Treatment of vulvar intraepithelial neoplasia with topical imiquimod","volume":"358","author":"M van Seters","year":"2008","journal-title":"N Engl J Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/00128360-200310000-00011","article-title":"Treatment of vaginal intraepithelial neoplasia (primarily low grade) with imiquimod 5% cream","volume":"7","author":"HW Buck","year":"2003","journal-title":"J Low Genit Tract Dis"},{"key":"ref35","first-page":"1015","article-title":"Topical imiquimod for acyclovir-unresponsive herpes simplex virus 2 infection","volume":"137","author":"J Gilbert","year":"2001","journal-title":"Arch Dermatol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1086\/322007","article-title":"Application of a topical immune response modifier, resiquimod gel, to modify the recurrence rate of recurrent genital herpes: a pilot study","volume":"184","author":"SL Spruance","year":"2001","journal-title":"J Infect Dis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1517\/13543784.2013.749236","article-title":"Resiquimod, a topical drug for viral skin lesions and skin cancer","volume":"22","author":"T Meyer","year":"2013","journal-title":"Expert Opin Investig Drugs"},{"article-title":"The Immune System","year":"2009","author":"P. P.","key":"ref38"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4049\/jimmunol.176.1.157","article-title":"The TLR-7 agonist, imiquimod, enhances dendritic cell survival and promotes tumor antigen-specific T cell priming: relation to central nervous system antitumor immunity","volume":"176","author":"RM Prins","year":"2006","journal-title":"J Immunol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"F19","DOI":"10.1084\/jem.20020073","article-title":"Adjuvants of immunity: harnessing innate immunity to promote adaptive immunity","volume":"195","author":"A Bendelac","year":"2002","journal-title":"J Exp Med"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/j.vaccine.2004.01.037","article-title":"Resiquimod is a modest adjuvant for HIV-1 gag-based genetic immunization in a mouse model","volume":"22","author":"M Otero","year":"2004","journal-title":"Vaccine"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","article-title":"Vaccine adjuvants: putting innate immunity to work","volume":"33","author":"RL Coffman","year":"2010","journal-title":"Immunity"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0042-6822(02)00038-7","article-title":"Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates","volume":"306","author":"JW Hooper","year":"2003","journal-title":"Virology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1016\/j.vaccine.2010.05.023","article-title":"Single-shot immunization with recombinant adenovirus encoding vaccinia virus glycoprotein A27L is protective against a virulent respiratory poxvirus infection","volume":"28","author":"R Rudraraju","year":"2010","journal-title":"Vaccine"},{"key":"ref45","unstructured":"Klimpel GR. Immune Defenses. In: <italic>Medical Microbiology<\/italic>. Edited by Baron S. 4th ed. Galveston (TX); 1996."},{"key":"ref46","first-page":"70","article-title":"Encyclopedia of Virology","author":"AJ Zajac","year":"2008"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"10010","DOI":"10.1128\/JVI.00601-06","article-title":"Human T-cell responses to vaccinia virus envelope proteins","volume":"80","author":"J Tang","year":"2006","journal-title":"J Virol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"5666","DOI":"10.1128\/IAI.73.9.5666-5674.2005","article-title":"Optimization of codon usage enhances the immunogenicity of a DNA vaccine encoding mycobacterial antigen Ag85B","volume":"73","author":"HJ Ko","year":"2005","journal-title":"Infect Immun"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1128\/JVI.72.2.1497-1503.1998","article-title":"Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage","volume":"72","author":"S Andre","year":"1998","journal-title":"J Virol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"7250","DOI":"10.1128\/IAI.69.12.7250-7253.2001","article-title":"Codon optimization of gene fragments encoding Plasmodium falciparum merzoite proteins enhances DNA vaccine protein expression and immunogenicity in mice","volume":"69","author":"DL Narum","year":"2001","journal-title":"Infect Immun"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/j.vaccine.2003.09.052","article-title":"Imiquimod and resiquimod in a mouse model: adjuvants for DNA vaccination by particle-mediated immunotherapeutic delivery","volume":"22","author":"LL Thomsen","year":"2004","journal-title":"Vaccine"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1099\/0022-1317-81-10-2341","article-title":"Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures","volume":"81","author":"S Goodbourn","year":"2000","journal-title":"J Gen Virol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0123113","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T16:04:48Z","timestamp":1747929888000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0123113"}},"subtitle":[],"editor":[{"given":"John S","family":"Tregoning","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,4,13]]},"references-count":52,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,4,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0123113","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2015,4,13]]}}}